Uso do sulfato de magnésio na prevenção e tratamento da pré-eclâmpsia grave: revisão de literatura
Revista ft · 2026-06-16 · 30 (159) · 01-19
DOI: 10.69849/25fms331 ↗At a glance
Journal article in Revista ft, published online on 2026-06-16. Written by Andara Teixeira Bezerra Lopes and 1 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Hypertensive syndromes of pregnancy constitute one of the main causes of maternal and perinatal morbidity and mortality worldwide, with severe pre-eclampsia and eclampsia accounting for a significant portion of these adverse outcomes, especially in low- and middle-income countries. In this context, magnesium sulfate (MgSO₄) has become established as the first-line pharmacological intervention for the prevention and treatment of eclamptic seizures. This study aimed to critically synthesize the scientific evidence on the clinical efficacy, safety profile, and different therapeutic regimens of MgSO₄ in the management of severe pre-eclampsia and eclampsia, as well as to discuss its applicability in healthcare settings with structural limitations. This is an integrative literature review, conducted through a systematic search of the PubMed/MEDLINE, SciELO, Embase, and Cochrane Library databases, encompassing publications between 2010 and 2024. Randomized clinical trials, systematic reviews, meta-analyses, international guidelines, and observational studies relevant to the topic were included. The analysis of the evidence demonstrates that MgSO₄ significantly reduces the incidence of eclampsia, with a reduction of more than 50% in the risk of seizures, in addition to presenting a favorable safety profile when administered under adequate clinical monitoring. Recent evidence also indicates that abbreviated maintenance regimens, between 6 and 12 hours, may present comparable efficacy to the conventional 24-hour regimen in selected contexts, although methodological limitations still exist in the available studies. In conclusion, magnesium sulfate remains a fundamental pillar in the management of hypertensive syndromes of pregnancy, its effectiveness being contingent upon the implementation of standardized clinical protocols, the training of healthcare teams, and the expansion of access to the medication, particularly in healthcare services with limited resources.
Cite
APA
Lopes, A. T. B., & Sá, S. M. D. (2026). Uso do sulfato de magnésio na prevenção e tratamento da pré-eclâmpsia grave: revisão de literatura. Revista ft, 30(159), 01-19. https://doi.org/10.69849/25fms331
Vancouver
Lopes ATB, Sá SMD. Uso do sulfato de magnésio na prevenção e tratamento da pré-eclâmpsia grave: revisão de literatura. Revista ft. 2026;30(159):01-19. doi:10.69849/25fms331
BibTeX
@article{Lopes2026,
author = {Lopes, Andara Teixeira Bezerra and Sá, Sarah Mourão de},
title = {Uso do sulfato de magnésio na prevenção e tratamento da pré-eclâmpsia grave: revisão de literatura},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {159},
pages = {01--19},
doi = {10.69849/25fms331}
}
EUVIMED